BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

206 hedge funds and large institutions have $1.62B invested in BioCryst Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 29 closing their positions.

Holders
206
Holders Change
+9
Holders Change %
+4.57%
% of All Funds
3.18%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
38
Increased
74
Reduced
55
Closed
29
Calls
$77.9M
Puts
$38.7M
Net Calls
+$39.2M
Net Calls Change
+$1.69M

Top Buyers

1
PAMS
1
Pictet Asset Management (Switzerland)
Switzerland
$70M
2
RM
2
RP Management
New York
$43M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$54M
4
BNP Paribas Asset Management
4
BNP Paribas Asset Management
France
$26.2M
5
SI
5
Sofinnova Investments
California
$20.9M

Top Sellers

1
HM
1
HealthCor Management
New York
$32.9M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$16.9M
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$668K
4
Northern Trust
4
Northern Trust
Illinois
$25.8M
5
Citadel Advisors
5
Citadel Advisors
Florida
$5.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
Lazard Asset Management
226
Lazard Asset Management
New York
– -$46K -3,238 Closed
PHK
227
Point72 Hong Kong
Hong Kong
– -$28K -1,981 Closed
BFEC
228
Benjamin F. Edwards & Company
Missouri
– -$10K -700 Closed
6 7 8 9
10